|
|
||||||||
The Journal of Immunology, Vol 159, Issue 3 1482-1489, Copyright © 1997 by American Association of Immunologists
ARTICLES |
EM Campbell, AE Proudfoot, T Yoshimura, B Allet, TN Wells, AM White, J Westwick and ML Watson
Department of Pharmacology, University of Bath, United Kingdom.
To characterize the biologic activities of potential mediators of allergic inflammation, we have cloned, expressed, and purified guinea pig RANTES (gpRANTES). cDNA for gpRANTES was cloned from Con A- stimulated guinea pig spleen cells. A high level of gpRANTES expression in Escherichia coli was achieved by mutation of a human RANTES (hRANTES) expression construct to obtain a 68-amino acid protein identical with the predicted guinea pig amino acid sequence, assuming an equivalent amino terminus as the human protein. Purified gpRANTES was an effective stimulus of human eosinophils as assessed by increases in intracellular free calcium in fura-2-loaded cells and chemotactic responses in vitro. gpRANTES exhibits similar potency and efficacy to hRANTES. In marked contrast, neither gpRANTES nor hRANTES was able to activate guinea pig peritoneal eosinophils in these assays, even in the presence of IL-5. However, gpRANTES was found to be a potent stimulator of guinea pig peritoneal macrophages. Following tracheal instillation of gpRANTES, a dose-dependent increase in macrophages, but not eosinophils, was observed in gpBAL. Macrophage accumulation was detectable by 6 h and sustained for at least 48 h. These results indicate that RANTES in the guinea pig may have a different cellular selectivity than that described in the human, which may be important in the use of animal models in the analysis of allergic disorders. These selectivities do not appear to be accounted for by differences in guinea pig and human RANTES sequences.
This article has been cited by other articles:
![]() |
T. A. Skwor, H. Cho, C. Cassidy, T. Yoshimura, and D. N. McMurray Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages J. Leukoc. Biol., December 1, 2004; 76(6): 1229 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jeevan, T. Yoshimura, K. E. Lee, and D. N. McMurray Differential Expression of Gamma Interferon mRNA Induced by Attenuated and Virulent Mycobacterium tuberculosis in Guinea Pig Cells after Mycobacterium bovis BCG Vaccination Infect. Immun., January 1, 2003; 71(1): 354 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawahara, T. Nakasone, and M. Honda Dynamics of Gamma Interferon, Interleukin-12 (IL-12), IL-10, and Transforming Growth Factor {beta} mRNA Expression in Primary Mycobacterium bovis BCG Infection in Guinea Pigs Measured by a Real-Time Fluorogenic Reverse Transcription-PCR Assay Infect. Immun., December 1, 2002; 70(12): 6614 - 6620. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jeevan, T. Yoshimura, G. Foster, and D. N. McMurray Effect of Mycobacterium bovis BCG Vaccination on Interleukin-1{beta} and RANTES mRNA Expression in Guinea Pig Cells Exposed to Attenuated and Virulent Mycobacteria Infect. Immun., March 1, 2002; 70(3): 1245 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Klein, A. Talvani, P. M. R. Silva, M. A. Martins, T. N. C. Wells, A. Proudfoot, N. W. Luckacs, and M. M. Teixeira Stem Cell Factor-Induced Leukotriene B4 Production Cooperates with Eotaxin to Mediate the Recruitment of Eosinophils During Allergic Pleurisy in Mice J. Immunol., July 1, 2001; 167(1): 524 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Watson, A.-M. White, E. M. Campbell, A. W. Smith, J. Uddin, T. Yoshimura, and J. Westwick Anti-Inflammatory Actions of Interleukin-13 . Suppression of Tumor Necrosis Factor-alpha and Antigen-Induced Leukocyte Accumulation in the Guinea Pig Lung Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 1007 - 1012. [Abstract] [Full Text] |
||||
![]() |
I. Sabroe, D. M. Conroy, N. P. Gerard, Y. Li, P. D. Collins, T. W. Post, P. J. Jose, T. J. Williams, C. J. Gerard, and P. D. Ponath Cloning and Characterization of the Guinea Pig Eosinophil Eotaxin Receptor, C-C Chemokine Receptor-3: Blockade Using a Monoclonal Antibody In Vivo J. Immunol., December 1, 1998; 161(11): 6139 - 6147. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |